Showing 9,601 - 9,620 results of 30,886 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 100 ((ng decrease) OR (a decrease)) ))', query time: 1.27s Refine Results
  1. 9601
  2. 9602

    Study data in excel format. by Daniel Pestana (18121246)

    Published 2024
    “…In summary, clinically relevant psychological distress was observed in a majority of ICU HCW during the acceleration phase of the 1<sup>st</sup> wave of the COVID-19 pandemic but decreased rapidly as the 1<sup>st</sup> wave progressed. …”
  3. 9603

    Participant demographics at T1, T2 and T3. by Daniel Pestana (18121246)

    Published 2024
    “…In summary, clinically relevant psychological distress was observed in a majority of ICU HCW during the acceleration phase of the 1<sup>st</sup> wave of the COVID-19 pandemic but decreased rapidly as the 1<sup>st</sup> wave progressed. …”
  4. 9604
  5. 9605
  6. 9606

    Effect of rotenone and its cotreatment with yucca extract on oxidative and antioxidative stress markers. by Dalia E. Ali (14691625)

    Published 2023
    “…Data are represented as the mean ± SEM of eight animals in each group. (*) Significantly differs (<i>P</i> < 0.05) compared to control group; (#) significantly differs (<i>P</i> < 0.05) compared to rotenone alone treated group; (≡) significantly differs (<i>P</i> < 0.05) compared to rotenone + yucca (50mg/kg) treated group.…”
  7. 9607

    Development of a novel bioreactor and systems for suspension cell culture in biopharmaceutical production by Rajesh Sharma (6183845)

    Published 2021
    “…The heat flow data (metabolic heat) from the treated and normal cells showed a distinct decrease in the heat generation profile which indicated that the treated cells were viable but not as active as the normal (non-treated) cells. …”
  8. 9608

    Herbal medicine TLJN reduces deposition and Aβ levels in APP23 mice. by Ping He (33281)

    Published 2013
    “…Bar: 100 µm. ELISA was performed to measure insoluble Aβ40 and Aβ42 levels in the neocortex. …”
  9. 9609
  10. 9610

    Factors associated with changing indications for adenotonsillectomy: A population-based longitudinal study by Jeng-Wen Chen (5310389)

    Published 2018
    “…In the adult subgroup, a decreasing prevalence of infectious indications (<i>p</i> = 0.014) coincided with an increasing neoplastic indications (<i>p</i> = 0.001). …”
  11. 9611

    Potential signatures of adaptive introgression at <i>SLC30A9</i>. by Ana Roca-Umbert (17041620)

    Published 2023
    “…The red dot denoted the <i>SLC30A9</i> region. (D) Joint distribution of the U (10%, 50%, 100%) and Q95 (10%, 100%) statistics in CEU and CHB when using either YRI or ESN as unadmixed group. …”
  12. 9612

    Data Sheet 1_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  13. 9613

    Data Sheet 2_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  14. 9614

    Data Sheet 3_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  15. 9615

    Data Sheet 4_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  16. 9616

    Pyrvinium inhibits WNT signaling in a CK1α dependent manner. by Bin Li (39349)

    Published 2014
    “…Cells were treated with control or WNT3a conditioned media with or without 100 nM Pyrvinium. …”
  17. 9617

    Experimental design. by Xueyan Lin (448667)

    Published 2025
    “…The C and MNS group were gavaged with equal volume normal saline, the ML and MR group gavaged with lactulose at a dose of 10 mL/kg body weight and rifaximin at a dose of 50 mg/kg body weight respectively once a day for 8 weeks until the end of the experiment. …”
  18. 9618
  19. 9619
  20. 9620